Globally, approximately one in three of all adults suffer from multiple chronic conditions. Multi-morbidity expands the difficulty level and cost of care multifold. Multimorbid patients utilise more healthcare and social care resources than those with one or no chronic conditions with frequent hospital visits, exponentially longer stays and premature death.
Digital therapeutic solutions can instill lifestyle changes in comorbid patients in a sustainable way to enable positive health outcomes and reduced cost of care.
Wellthy Therapeutics had conducted a study among patients with cardio-metabolic chronic conditions
To showcase that the digital therapeutics solution can improve outcomes in patients with multimorbid conditions
The study showcaseshow a digital therapeutics based approach aided in positive and sustained patient outcomes which in turn resulted in high patient retention. And how It has also enhanced the overall patient experience and guaranteed better engagement.
Get the full report on how Wellthy Therapeutics help Pharmaceutical companies achieve improved access.
